Pulse nav.journalClub Debates ativos Tendências Explorar Perguntas Pesquisadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidade

Início Explorar nav.journalClub Tendências

⌘+K

Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma | Synapse

September 15, 2017Open Access

Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma

Key Points

Key points are not available for this paper at this time.

Abstract

UCAR T cells can overcome antigenic heterogeneity in GBM and lead to improved treatment outcomes.

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Bielamowicz et al. (Fri,) studied this question.

synapsesocial.com/papers/69de9acb7702a00918b0bfae https://doi.org/https://doi.org/10.1093/neuonc/nox182

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape2016 · 673 citations
2Convergence of Acquired Mutations and Alternative Splicing of <i>CD19</i> Enables Resistance to CART-19 Immunotherapy2015 · 1,254 citations
3Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies2007 · 135 citations
4Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes2014 · 81 citations
5Functional expression of chimeric receptor genes in human T cells2001 · 157 citations